Washout and Rescue Protocols in April 2026 IOP-Lowering Studies
Beta-blockers (e.g. timolol): These are typically washed out by stopping the drop for 4 weeks. Research showed that a 2-week break is usually too...
Deep research and expert guides on maintaining your visual health.
Beta-blockers (e.g. timolol): These are typically washed out by stopping the drop for 4 weeks. Research showed that a 2-week break is usually too...
Visual field loss from conditions like glaucoma can go unnoticed. Start a free trial and screen for potential blind spots in minutes.
Screening failure refers to when a person does not meet the required conditions during an early check before joining a medical study or receiving a particular procedure. These checks look at health history, test results, or other criteria to make sure participation is safe and that the study or treatment will produce meaningful information. If a personโs measurements fall outside the allowed range, or if they have a medical condition that could cause risk or interfere with results, they are considered a screening failure. This decision is made to protect the individual and to keep the integrity of the research or treatment plan. Screening failure matters because it helps prevent harm and ensures that studies or treatments are carried out under appropriate conditions. For the person screened, it may mean they need different medical care, additional testing, or follow-up rather than the original plan. For researchers and clinicians, higher rates of screening failure can increase the time and cost needed to enroll enough participants and can influence how broadly results apply to the general population. Clear communication about why someone failed screening and what next steps are recommended is important for fairness and patient care.